Given the far more convincing association of prostate cancer with both somatic and gATM PVs in metastatic disease among 18/263 (6.8% germline 1.9%), even this 1 BRCA1 PV appears unlikely to be a driver in that tumour. This evidence concerns the gene BRCA1 and neoplasm.